SoftMedx Healthcare Limited reported no changes in its share capital for the month ended 31 March 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Limited on 1 April 2026.

At month-end, the number of issued ordinary shares stood unchanged at 2.13 billion, with zero treasury shares outstanding. Consequently, total issued shares also remained at 2.13 billion.

SoftMedx affirmed that it met the Main Board’s minimum public-float requirement of 25% of issued share capital as of 31 March 2026.

The filing shows no activity in share options, warrants, convertible securities, share repurchases, or other equity-linked instruments during the period.

The company further confirmed that all regulatory and listing-rule obligations related to its share capital structure were duly satisfied for the reporting month, as evidenced by the declaration from Company Secretary Lam Sung Him Gaston.